1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Pharmaceuticals and Healthcare Report Q2 2016

United States Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 114 pages

Includes 3 FREE quarterly updates

BMI View: The US pharmaceutical market is, and will continue to remain, the most attractive globally.Due to ongoing challenges in Western Europe and emerging markets, drug companies should increasinglyprioritise the US for commercialisation efforts, as well as R&D and manufacturing investments. The keydownside risk to this positive outlook is increased pricing pressure from the government and other payers.

Headline Expenditure Projections

- Pharmaceuticals: USD333.4bn in 2015 to USD349.9bn in 2016; +4.9% growth. Market forecast revisedupwards since Q116 due to consideration and incorporation of new company sales data.

- Healthcare: USD3.1trn in 2015 to USD3.3trn in 2016; +5.0% growth. Forecast unchanged since Q315.

Table Of Contents

United States Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United States 2014-2020) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United States 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (United States 2014-2020) 32
Industry Risk Reward Index 33
Americas Risk/Reward Index 33
United States Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 56
Pricing and Reimbursement Regime 57
Late-2013 Government Shutdown 59
The November 2016 Presidential Election 61
Market Overview 63
Healthcare Sector 64
Table: Key Features Of The Affordable Care Act By Year 66
Table: Healthcare Resources (United States 2010-2015) 69
Table: Healthcare Personnel (United States 2010-2015) 69
Table: Healthcare Activity (United States 2010-2015) 70
Clinical Trials 70
Epidemiology 72
Competitive Landscape 75
Research-Based Industry 75
Table: Multinational Market Activity 75
Pharmaceutical Distribution 77
Pharmaceutical Retail Sector 77
Company Profile 78
Amgen 78
AstraZeneca 83
Eli Lilly 87
GlaxoSmithKline 91
Merck and Co 95
Pfizer 99
Demographic Forecast 103
Table: Population Headline Indicators (United States 1990-2025) 104
Table: Key Population Ratios (United States 1990-2025) 104
Table: Urban/Rural Population and Life Expectancy (United States 1990-2025) 105
Table: Population By Age Group (United States 1990-2025) 105
Table: Population By Age Group % (United States 1990-2025) 106
Glossary 108
Methodology 110
Pharmaceutical Expenditure Forecast Model 110
Healthcare Expenditure Forecast Model 110
Notes On Methodology 111
Risk/Reward Index Methodology 112
Index Overview 113
Table: Pharmaceutical Risk/Reward Index Indicators 113
Indicator Weightings 114

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.